Clinical Trials Directory

Trials / Completed

CompletedNCT04813731

COVID-19 And Lingering Symptoms In Primary Care Patients

Status
Completed
Phase
Study type
Observational
Enrollment
300 (actual)
Sponsor
Katarina Hedin · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The ongoing corona virus disease 2019 (COVID-19) is a viral acute respiratory tract infection caused by server acute respiratory syndrom coronavirus typ 2 (SARS-CoV-2). The signs and symptom of SARS-CoV-2 infection vary and most people with COVID-19 experience illness of mild or moderate severity and recover with symptomatic treatment outside of hospital. Studies have found that some people experience lingering/long-lasting symptoms and only a minority of patients were completely free from COVID-19 related symptoms after two months. About one third still had up to two residual symptoms and 55% had three or more. As far as we know no study on lingering symptoms has been published in patients after a mild or moderate infection managed in primary care settings. The aim of this study is to explore the course of disease over a one year period and describe lingering symptoms and their impact on well-being and daily activities in adult non-hospitalized patients with previous established COVID-19 infection.

Conditions

Timeline

Start date
2020-12-12
Primary completion
2022-06-30
Completion
2022-06-30
First posted
2021-03-24
Last updated
2025-09-04

Locations

13 sites across 11 countries: Belgium, Denmark, France, Georgia, Germany, Ireland, Italy, Netherlands, Poland, Romania, Sweden

Source: ClinicalTrials.gov record NCT04813731. Inclusion in this directory is not an endorsement.